SCHEMBL17153140

SCHEMBL17153140

CCCCNc1ccc(-c2ccnc(Nc3cccc(CO[Si](C)(C)C(C)(C)C)c3)n2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.49
PRKCD Q05655 2/20 0.49
PRKD3 O94806 1/20 0.49
EGFR P00533 1/20 0.49
PRKCG P05129 1/20 0.49
PRKCB P05771 1/20 0.49
LCK P06239 1/20 0.49
PRKCH P24723 1/20 0.49
PRKCI P41743 1/20 0.49
ZAP70 P43403 1/20 0.49
PRKCE Q02156 1/20 0.49
PRKCQ Q04759 1/20 0.49
PRKCZ Q05513 1/20 0.49
PRKD1 Q15139 1/20 0.49
ABL1 P00519 5/20 0.43
SRC P12931 2/20 0.43
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
BCR P11274 4/20 0.42
CDK1 P06493 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18412555 0.93 EGFR (0.54) PRKCAPRKCDPRKD3EGFRPRKCG
SCHEMBL17153269 0.92 EGFR (0.59) PRKCAPRKCDPRKD3EGFRPRKCG
SCHEMBL18412553 0.88 PRKCA (0.46) PRKCAPRKCDPRKD3EGFRPRKCG
SCHEMBL17153051 0.86 EGFR (0.47) PRKCAPRKCDPRKD3EGFRPRKCG
SCHEMBL17153131 0.83 ABL1 (0.47) PRKCAPRKCDEGFRABL1SRC
SCHEMBL17153153 0.83 PRKCA (0.42) PRKCAPRKCDPRKD3EGFRPRKCG
SCHEMBL17152843 0.83 PRKCA (0.42) PRKCAPRKCDPRKD3EGFRPRKCG
SCHEMBL17153274 0.81 PRKCA (0.42) PRKCAPRKCDPRKD3EGFRPRKCG
SCHEMBL18412554 0.81 PRKCA (0.42) PRKCAPRKCDPRKD3EGFRPRKCG
SCHEMBL17153041 0.80 CDK19 (0.41) PRKCAPRKCDABL1SRCBCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015150555-A1 MACROCYLIC PYRIMIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2015-10-08 WO disclosed